Allergy, Immunology, and ENTCardiovascularClinical PharmacologyCOPDDermatologyDiabetes and EndocrinologyIdiopathic Pulmonary FibrosisMusculoskeletal / RheumatologyObstetrics-Gynecology & Women's HealthOphthalmologyPediatricsPharmacyPsychiatry and Behavioral HealthRespiratoryUrology

Expert InterviewsMedical World NewsPodcasts

Partner Content

Advertise
Editorial Info
Contact Us
Terms & Conditions
Privacy Policy
Do Not Sell My Personal Information

© 2020 MJH Life Sciences and Formulary Watch. All rights reserved.

Spotlight

COPD

ClinicalSee All >

Allergy, Immunology, and ENT
Cardiovascular
Clinical Pharmacology
COPD
Dermatology
Diabetes and Endocrinology
Idiopathic Pulmonary Fibrosis
Musculoskeletal / Rheumatology
Obstetrics-Gynecology & Women's Health
Ophthalmology
Pediatrics
Pharmacy
Psychiatry and Behavioral Health
Respiratory
Urology

Advertise
Editorial Info
Contact Us
Terms & Conditions
Privacy Policy
Do Not Sell My Personal Information

© 2020 MJH Life Sciences^™ and Formulary Watch. All rights reserved.

FDA warns of serious blood disorder resulting from abuse of Opana ER

November 1, 2012

FDA has warned patients of TTP, a serious blood disorder that results from misuse of Opana ER.